Back to search

A Randomized, Double-Blind, Controlled Withdrawal Trial in Crohn’s Disease Patients in Long-term Remission on Azathioprine

Data up to Jan 2025

Published2005
Citations344
References40
Clinical Trials (1)

Total Citations Per Year

Abstract

References (40)

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples

1977 • 8,468 citations

Treatment of Crohn's Disease with 6-Mercaptopurine

1980 • 1,055 citations

Azathioprine and 6-Mercaptopurine in Crohn Disease

1995 • 966 citations

“Proving the null hypothesis” in clinical trials

1982 • 870 citations

Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID).

1989 • 833 citations

Low-Molecular-Weight Heparin in the Treatment of Patients with Venous Thromboembolism

1997 • 785 citations

6-Mercaptopurine in the Management of Inflammatory Bowel Disease: Short- and Long-Term Toxicity

1989 • 757 citations

A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease

2000 • 724 citations

The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review

2002 • 642 citations

A controlled double blind study of azathioprine in the management of Crohn's disease.

1995 • 583 citations

Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI)

1979 • 566 citations

Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease

1994 • 501 citations

Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.

1993 • 501 citations

Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine

1996 • 480 citations

Crohn's Disease and Cancer

1973 • 473 citations

A Trial of Shortened Zidovudine Regimens to Prevent Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1

2000 • 439 citations

Smoking cessation and the course of Crohn's disease: An intervention study

2001 • 419 citations

Significance Testing to Establish Equivalence between Treatments, with Special Reference to Data in the Form of 2 x 2 Tables

1977 • 400 citations

Azathioprine for maintenance of remission in Crohn's disease

1998 • 318 citations

Crohn's disease and cancer: A population-based cohort study

1994 • 311 citations

Epstein-Barr virus–positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine

2002 • 271 citations

Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low

2000 • 265 citations

Proving the null hypothesis.

1991 • 259 citations

Azathioprine for maintenance of remission in Crohn's disease: Benefits outweigh the risk of lymphoma

2000 • 251 citations

The relationship between infliximab treatment and lymphoma in Crohn's disease

1999 • 208 citations

Long‐term risk of malignancy after treatment of inflammatory bowel disease with azathioprine

2002 • 201 citations

Risk of lymphoma in inflammatory bowel disease

2000 • 151 citations

Risk of lymphoma in inflammatory bowel disease

2000 • 148 citations

Malignant Neoplasms Subsequent to Treatment of Inflammatory Bowel Disease With 6-Mercaptopurine

1999 • 141 citations

Epstein-Barr Virus–Positive Primary Gastrointestinal Hodgkin's Disease

2000 • 126 citations

Fatal infectious mononucleosis: a severe complication in the treatment of Crohn's disease with azathioprine.

1995 • 93 citations

Optimum Duration of Treatment With 6-Mercaptopurine for Crohn's Disease

1999 • 79 citations

Cancer Clinical Trials

1988 • 40 citations

Prediction of relapse in patients with Crohnʼs disease in remission

1994 • 31 citations

An unusual complication of immunosuppressive therapy in inflammatory bowel disease.

1997 • 23 citations

Immunosuppressors for Inflammatory Bowel Disease: How Long Is Long Enough?

2000 • 19 citations

Biological markers of short term relapse in Crohn's disease (CD)

2001 • 18 citations

Immunosuppressors for inflammatory bowel disease: How long is long enough?

2007 • 9 citations

Fatal infectious mononucleosis

1995 • 1 citations

Deleted Work

1955 • 0 citations

Cited By (0)

No citing papers found in database

A Randomized, Double-Blind, Controlled Withdrawal Trial in Crohn’s Disease Patients in… (2005) – Gastroenterology | Metascience Observatory Explorer